Homnick Douglas N
Human Development, Division of Pediatric Pulmonology, Cystic Fibrosis Center Director, Michigan State University, Kalamazoo Center for Medical Studies, Kalamazoo, Michigan, USA.
Paediatr Respir Rev. 2007 Mar;8(1):40-5. doi: 10.1016/j.prrv.2007.02.002. Epub 2007 Mar 26.
Airway clearance therapy (ACT) requires a substantial time, effort and resource commitment on the part of families and patients with cystic fibrosis (CF). Lack of compliance with caregiver recommendations and adherence to a proposed therapeutic plan occurs more than 50% of the time with ACT and is particularly common in adolescents. There is a large menu of ACT devices and techniques from which to choose. Increasing adherence and compliance requires an effort on the part of the CF team, including regular visits to the CF center, matching the patient to the device or technique based on lifestyle and disease severity, selecting appropriate outcome measures and monitoring adherence and compliance. Successful ACT also requires the CF team to understand individual patient situations, individualize ACT programs and accept a realistic level of patient participation.
气道清除疗法（ACT）需要囊性纤维化（CF）患者及其家庭投入大量时间、精力和资源。在进行ACT时，超过50%的情况会出现患者未遵循护理人员建议以及未坚持既定治疗方案的问题，这在青少年中尤为常见。ACT有大量的设备和技术可供选择。提高依从性和顺应性需要CF团队付出努力，包括定期前往CF中心就诊，根据生活方式和疾病严重程度为患者匹配合适的设备或技术，选择恰当的疗效评估指标，以及监测依从性和顺应性。成功的ACT还要求CF团队了解患者的具体情况，制定个性化的ACT方案，并接受患者切实可行的参与程度。
